About Us

        Jiangxi Zhongke Jiufeng Intelligent Medical Technology Co., Ltd. ("JF") was established in May 2015 by Mr. Frank Wu, former CEO of Siemens Medical – Northeast Asia, together with top-tier scientists, clinical experts and seasoned managers with oversea training and working experience. JF enters primary care market with medical imaging solutions powered by AI and telehealth techniques, to enable high quality, timely, and economic diagnostic services at grassroots healthcare facilities for locals. Such effort tremendously improves the coordination within China’s tiered-healthcare system and helps poverty alleviation, since health problems account for almost half of the poverty in China. 


        JF is a high-tech company which integrates AI, big data and cloud computing to provide medical imaging solutions. JF was among the first to establish an AI medical imaging diagnosis service platform for the vast villages and towns, remote areas, and grassroots communities. JF’s model is powered by high-tech, endorsed by governments, led by professional guidance, implemented at grassroots, extended in the tired-healthcare system, and featured by innovation.


        “Benevolent people care for others thru non-stop innovative upgrade and update", JF is dedicated to create a participatory platform of smart care and Internet of Everything to enable high quality care at low cost, starting a new era of human health.

Milestone

2019


July     Ranked No. 1 in the world on Stanford's CheXpert 

              leaderboard. Significantly, the JF team 

              outperformed all three radiologists on the test 

              set, demonstrating the role that AI can play in 

              providing precise medical diagnostics

July    Granted by the State Key Project of Science and 

            Technology

July    Invited presentation at the 2nd Conference of Medical 

            and Health Sciences – “The 4th Industry Revolution 

            and Healthcare”, Raman University, Malaysia 

June    Invited presentation at the 4th Central Asian 

            Conference on Tuberculosis Control, Nursultan, 

            Kazakhstan

June    Listed in the "National Brand Project" by Xinhua 

            News Agency 

April    Closed a major financing round led by GreyBird 

            Ventures  (GreyBird Ventures's first investment 

            project in the Asia-Pacific region) 

April    Listed in the "Frontier Achievements of Science 

            and Technology, 2019" by the Chinese Association 

            of Science and Technology

April    Visited by ZHAO Lejie, the Standing Committee 

            Member of the Political Bureau of the CPC Central 

            Committee and Secretary of the Discipline 

            Commission of the CPC Central Committee

2018

December   Signed a Cooperation Agreement with Chinese 

                    Anti-TB Association to co-establish the national 

                    TB big data platform

December   The demonstration project of "Poverty 

                    Alleviation thru TB Reduction" in Zhangjiakou 

                    via empowering 210 township healthcare 

                    centers was highly recognized by the 

                    National Health Commission

October      Received CFDA clearance (Class II) 

August        Ranked No. 1 in the world on Stanford's MURA 

                    leaderboard

May            Highly recognized by the Chinese Anti-TB 

                    Association in an AI vs Radiologist test

February     Received copyright certificate of multiple 

                    intellectual properties 

January      Published an Enterprise Standard on DR 

                    medical digital imaging diagnosis platform 

                    based on artificial intelligence for the first 

                    time in China

                   

2017

October   Prestigious medical imaging experts joined JF; 

                  R&D Center of Medical AI established in 

                  Nanjing

June        The "Yuanzhou Model" of empowering primary 

                  care was recognized by Jiangxi Provincial 

                  Government

May         Certified by China Association of Medical 

                  Equipment as "National Demonstration 

                  Base of Telehealth"

January    The Operating Center in Nanchang High-tech 

                  Zone  started to run


2016

December   Kicked off the model of empowering 

                    grassroots hospitals

December   Certified as an Academician Workstation 

                    of Chinese Academy of Engineering 

April           Established Nanchang Medical Imaging 

                    Research Institute with the Chinese 

                    Academy of Sciences


2015

December    Received a governmental grant for technology 

                      transformation 

August         The cloud-based medical imaging center 

                      officially started and successfully processed 

                      the first case of remote image reading 

May             Registered in Nanchang


  • 3million

    Provided nearly 3000000 medical imaging reading services for grass-roots hospitals

  • 15

    Patents for Invention(IP)

  • 1

    Patent for Utility Models

Powerful medical transformation platform

State-of-the-Art Technology

JF has been dedicated to improve the quality of medical care at grassroots level and to optimize the coordination of the medical service network. 

JF partners with Greybird Ventures, Harvard Medical School and other technical leaders in the globe to develop cutting-edge technologies to fulfil the mission. The establishment of "National Demonstration Base of Telehealth" by China Association of Medical Equipment, the “Mobile Medical Imaging Research Institute of Chinese Academy of Sciences (Nanchang)”, and the “Academician Workstation (Prof. Fan Daiming) of Chinese Academy of Engineering” have provided powerful technical support for JF.

Academician Prof. FAN DaimingAcademician

Head of JF Academician Workstation


Prestigious medical scientist

Doctoral supervisor

, Vice-president and Academician of Chinese Academy of Engineering

, Former President of the Fourth Military Medical University

Committee Member of the Chinese Digestive Disease Society

, Vice- Chairman of the Chinese Society of Internal Medicine

President of China Anti-cancer Association


Tom MillerFounder of GreyBird Ventures

The 1st venture capital for precision medicine in the U.S. 

Famous KOL of medical innovation 

Former Board Member of Siemens Healthcare and Carl Zeiss

Expert advisor on healthcare reform for Clinton and Obama governments

Committee Member of Personalized Medicine in Harvard University


  • Management Headquarters

    10th Floor, Jialong Tower, Yard 1, Dongsanhuan South Road, Chaoyang District, Beijing

  • R & D Center

    Tower C, 8th Floor, Huangpu Tower, #2, Huangpu Road, Xuanwu District, Nanjing, Jiangsu

  • Operating Center

    Building No.5-7, No. 699, Tianxiang Avenue, Hi-Tech Zone, Nanchang, Jiangxi

Management Headquarters

10th Floor, Jialong Tower, Yard 1, Dongsanhuan South Road, Chaoyang District, Beijing

R & D Center

Tower C, 8th Floor, Huangpu Tower, #2, Huangpu Road, Xuanwu District, Nanjing, Jiangsu

Operating Center

Building No.5-7, No. 699, Tianxiang Avenue, Hi-Tech Zone, Nanchang, Jiangxi

税法电子版